PM

Patrick Mooney

CEO

SpyGlass Pharma, Inc.

Southlake, Texas


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
SpyGlass Pharma, Inc.
Industry
pharmaceuticals
Employees
41.0
Seniority
C suite
Annual Revenue
2100000.0
Total Funding
117500000.0
Latest Funding
Series C

Technologies

Outlook Google Cloud Hosting Wix Google Tag Manager Varnish Mobile Friendly Shutterstock Remote AI

Keywords

pharmaceutical manufacturing intraocular drug delivery bimatoprost delivery cataract surgery glaucoma treatment ocular hypertension management controlled release drug eluting pads sustained delivery iop lowering ophthalmic innovation long-term therapy fda investigational surgical techniques iol (intraocular lens) hydrophobic acrylic vision restoration eye pressure management safety & efficacy clinical trials injectable drug delivery continuous release patient adherence eye care technology ophthalmology advancements unmet medical needs chronic eye conditions innovative ophthalmic solutions surgical implantation clinical study enrollment patient outcomes ophthalmic diseases drug delivery platform anti-glaucoma therapy bioadaptive systems device integration surgical device commercialization strategy medical device engineering biotechnology vision care solutions peer-reviewed studies medical device patents ophthalmic research eye treatment options pipeline development drug efficacy clinical data support patient compliance ophthalmic surgical procedures novel therapeutic approaches pharmaceuticals medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans